New combo therapy shows promise for Hard-to-Treat cancers
NCT ID NCT03697304
First seen Jan 27, 2026 · Last updated Jun 16, 2026 · Updated 19 times
Summary
This study tested a new immunotherapy drug, ezabenlimab, combined with other cancer medicines in 211 adults with advanced solid tumors that had spread. The goal was to see if the tumors shrank or disappeared. Participants received different drug combinations, and doctors monitored their health and side effects. The trial is complete, and results help guide future treatment options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beatson West of Scotland Cancer Centre
Glasgow, G12 0YN, United Kingdom
-
Cross Cancer Institute (University of Alberta)
Edmonton, Alberta, T6G 1Z2, Canada
-
Florida Cancer Specialists - East
West Palm Beach, Florida, 33401, United States
-
Florida Cancer Specialists-Fort Myers-52980
Fort Myers, Florida, 33901, United States
-
Florida Cancer Specialists-Saint Petersburg-52979
St. Petersburg, Florida, 33705, United States
-
Florida Cancer Specialists-Sarasota-61670
Tallahassee, Florida, 32308, United States
-
Guy's Hospital
London, SE1 9RT, United Kingdom
-
Indiana University
Indianapolis, Indiana, 46202, United States
-
Medical College Of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Norton Cancer Institute
Louisville, Kentucky, 40202, United States
-
Oklahoma University School of Community Medicine
Oklahoma City, Oklahoma, 73104, United States
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 1Z6, Canada
-
Sarah Cannon Research Institute, London
London, W1G 6AD, United Kingdom
-
Tennessee Oncology
Chattanooga, Tennessee, 37404, United States
-
Tennessee Oncology, PLLC-Nashville-52568
Nashville, Tennessee, 37203, United States
-
University College Hospital
London, NW1 2BU, United Kingdom
-
University of California San Diego
La Jolla, California, 92093, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.